| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 19.410 | 27.099 | 65.678 | 67.852 | 55.408 | 57.394 | 36.973 | 63.548 | 66.964 |
| Total Income - EUR | 0 | 19.410 | 27.120 | 65.976 | 67.852 | 55.634 | 57.395 | 36.973 | 63.548 | 66.964 |
| Total Expenses - EUR | 2.479 | 11.804 | 18.942 | 47.945 | 59.020 | 51.626 | 50.796 | 41.210 | 49.274 | 54.831 |
| Gross Profit/Loss - EUR | -2.479 | 7.606 | 8.179 | 18.031 | 8.832 | 4.008 | 6.599 | -4.237 | 14.274 | 12.133 |
| Net Profit/Loss - EUR | -2.479 | 7.024 | 7.365 | 16.051 | 6.796 | 2.406 | 5.014 | -5.347 | 12.026 | 10.302 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Impactmed-Stoma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 126 | 2.169 | 1.831 | 30.344 | 26.019 | 29.542 | 29.985 | 26.567 | 22.638 | 19.011 |
| Current Assets | 162 | 7.814 | 7.963 | 1.535 | 3.854 | 4.822 | 4.562 | 1.219 | 2.180 | 3.765 |
| Inventories | 0 | 0 | 0 | 236 | 0 | 0 | 0 | 0 | 1 | 1 |
| Receivables | 0 | 0 | 36 | 0 | 0 | 471 | 0 | 0 | 12 | 12 |
| Cash | 162 | 7.814 | 7.927 | 1.298 | 3.854 | 4.351 | 4.562 | 1.219 | 2.167 | 3.752 |
| Shareholders Funds | -2.434 | 4.615 | 7.418 | 23.333 | 29.677 | 31.521 | 35.836 | -5.299 | 6.441 | 16.706 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.723 | 5.369 | 2.376 | 8.546 | 8.173 | 7.544 | 251 | 33.085 | 18.428 | 6.069 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Impactmed-Stoma Srl